Results 151 to 160 of about 262,234 (355)
Consumer Willingness to Pay for Irradiated Poultry Products [PDF]
A probit model for whether or not consumers would buy irradiated poultry products is estimated jointly with an OLS equation for the price premiums that consumers are willing to pay for irradiated chicken breast meat.
Huang, Chung L. +2 more
core +1 more source
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Workplace Safety: Estimating Workers' Marginal Willingness to Pay [PDF]
The aim of the present paper is to empirically estimate the monetary value workers place on safer working conditions. The marginal willingness to pay for workplace safety is estimated using data on job durations together with data on accident risks and ...
Norin, Anna
core +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Temporal Reliability of Willingness to Pay from the National Survey of Fishing, Hunting, and Wildlife-Associated Recreation [PDF]
The U.S. Fish and Wildlife Service's National Survey of Fishing, Hunting, and Wildlife Associated Recreation has been a source of information on wildlife-related recreation since 1955. The contingent valuation method has been used to estimate willingness
John C. Whitehead, Richard Aiken
core
Customer concerns about uncertainty and willingness to pay in leasing solar power systems
L. H. Shih, Tse-Yuen Chou
openalex +2 more sources
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
An analysis of the relationship between risk perceptions and willingness‐to‐pay for commodities during the
Ou Li, Da Qian
openalex +1 more source
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source

